Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoChange Detected- The page now includes a new revision label v3.5.4 in the revision history. The older revision v3.5.3 and related topics (Melanoma and MedlinePlus Genetics) were removed from the related topics list.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s “related topics”/metadata area was updated (including the displayed revision/version). This reflects a non-substantive update to informational links rather than changes to the study record itself.SummaryDifference0.2%

- Check33 days agoChange DetectedAdded Revision: v3.5.2; removed Melanoma, related topics: MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics to the Related Topics section.SummaryDifference0.2%

- Check56 days agoChange DetectedMelanoma and related topics, including MedlinePlus Genetics, were removed from the page.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the study page. The revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.